Przejdź do
EHU149201
MISSION® esiRNA
targeting human CC2D2B (1)
Wybierz wielkość
| Rozmiar/SKU | Dostępność | Cena netto |
|---|---|---|
20 μg | Wysyłka zazwyczaj następuje w ciągu 3 tygodni (od 4 do 6 tygodni w przypadku zamówień niestandardowych). | 956,00 zł |
50 μg | Wysyłka zazwyczaj następuje w ciągu 3 tygodni (od 4 do 6 tygodni w przypadku zamówień niestandardowych). | 1720,00 zł |
Informacje o tej pozycji
956,00 zł
description
Powered by Eupheria Biotech
Quality Segment
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
GCAGCTCATTGATAGCGAAATACATCAAAGGTCCAAGTTGTCTCCACAGACTGAAGTCTCATTGGATGAAAGTCTTTCATTTTTCATTCTGAGTGGTGAAGAAGGTTCAGCTTTGGGCAAGTCTTCAGAGCAGAGACCAGTAAACCGTAGTTATCCCAAATGCTTTTCACTTGGTGTTAATTTACAAAATGTTGCTGAGAGTGAAGAGGAAGAGTTTATGAAAGAATTCATTTTGACAGATATACTCAAAGTAAAAGCTGCTGACTATGAAGATGATCAAGAACAAATAAAAAAACAGAAGGCAAATATTTTTGTACCAAGTAGTTCTCCAGTGGTTAACCAGCGCAAACTGCCAAAAGATATGATGCCACGTATTCTAGAAGATGAAGGATTCTATATTCAGAGAAAGCCAGAAATATACAAAAAGACCTGCAACAAAATGGAAAATCGCCTG
Ensembl | human accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
human ... CC2D2B(387707), C10orf131(100127889)
General description
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
1 of 1
Ta pozycja | ||
|---|---|---|
| description targeting human CC2D2B (1) | description targeting human CC2D2B (2) | description Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody |
| product line MISSION® | product line MISSION® | product line Prestige Antibodies® Powered by Atlas Antibodies |
| esiRNA cDNA target sequence GCAGCTCATTGATAGCGAAATACATCAAAGGTCCAAGTTGTCTCCACAGACTGAAGTCTCATTGGATGAAAGTCTTTCATTTTTCATTCTGAGTGGTGAAGAAGGTTCAGCTTTGGGCAAGTCTTCAGAGCAGAGACCAGTAAACCGTAGTTATCCCAAATGCTTTTCACTTGGTGTTAATTTACAAAATGTTGCTGAGAGTGAAGAGGAAGAGTTTATGAAAGAATTCATTTTGACAGATATACTCAAAGTAAAAGCTGCTGACTATGAAGATGATCAAGAACAAATAAAAAAACAGAAGGCAAATATTTTTGTACCAAGTAGTTCTCCAGTGGTTAACCAGCGCAAACTGCCAAAAGATATGATGCCACGTATTCTAGAAGATGAAGGATTCTATATTCAGAGAAAGCCAGAAATATACAAAAAGACCTGCAACAAAATGGAAAATCGCCTG | esiRNA cDNA target sequence GGAAATGGAACTGAAGAACTCTGTCTTTTGACATCAGGAAAACTTAGCTATTCTCTATCATGGAGCTTAGATGAAAATGGTCTTCCTCTGATACCTATGCCACAATCATTAAGATCTTCTTACTGCAGTATGTTAAGGAATGTAGATGCAAGAAGTGTTCCTGGAATTCCATGGCTCATGAATGAACAGAAGCTTTTTGAATGGGCAAATGAAGTCAGAATTGATCCAAATAATCCAGAATATTCTGATTTAATGGAATCTGTTACGTACATGAGACTTAAGGGGCAGGATATTCCAAAGTATTTTCGTCTTGAACAGTTGCAAGATGAATTTAACTTCGTTTCTGAAGAGGAAATGGCAAAGAGTAAACGTTTCCAGCTATTGCAACTTAGAAATGCAGGTCAATTAGATAATTTCCTTCTACAGCAAATGCCCCTCCATGATACAGAGATTCCAGATTTAGTCTTCCAGCCAGGTGCAGTGACTCATGCCTGTAATCTTGGCACTCTGGGGA | esiRNA cDNA target sequence - |
| Ensembl | human accession no. | Ensembl | human accession no. | Ensembl | human accession no. - |
| Gene Information human ... CC2D2B(387707), C10orf131(100127889) | Gene Information human ... CC2D2B(387707) | Gene Information human ... CC2D2B(387707) |
| form lyophilized powder | form lyophilized powder | form buffered aqueous glycerol solution |
| NCBI accession no. | NCBI accession no. - | NCBI accession no. - |
Wybierz jedną z najnowszych wersji:
Masz już ten produkt?
Dokumenty związane z niedawno zakupionymi produktami zostały zamieszczone w Bibliotece dokumentów.